dimensional echocardiography, presence of calcification, angiographic valve ring diameter, maximum diameter of balloon used, the number of balloons used (single or double), pressure gradient measured, and degree of aortic regurgitation (AR) graded by either Doppler echocardiography or aortography. The double balloon diameter was converted to a single balloon diameter by Yeager's formula. 10 
Outcome of PTAV
The efficacy of PTAV was judged by a reduction of the pressure gradient and the development of AR. If the residual pressure gradient after PTAV was less than 50 mmHg and the pressure gradient decrease more than 20 mmHg, the effect on the gradient was determined as good. The severity of AR was graded as none, trivial (a narrow jet just reaching the aortic valve), slight (a jet confined to the left ventricular (LV) outflow tract on echocardiography or aortography), moderate (the jet reached the midportion of the left ventricle on echocardiography or there was whole LV opacification on angiography) or severe (the jet reached the LV apex on echocardiography or LV opacification was denser than the ascending aorta on aortography). When the grade assessed by echocardiography and aortography did not agree, we used the angiographic grade. We arbitrary determined AR as significantly worsened if it increased by more than 2 grades. From the questionnaire answers, we analyzed factors that might determine the outcome of PTAV in respect to the pressure gradient and AR.
Follow-up
If the procedure effectively reduced the pressure gradient and did not make the AR worse, it was judged clinically effective. Follow-up data after a clinically effective proce- dure was analyzed in respect to progression of AR and redevelopment of the pressure gradient.
Statistical Analysis
Statistical analysis was performed with paired-or unpaired-t test, chi square test, or Mann-Whitney's U test using StatView v5.0 software (Abacus concepts Inc, Berkeley, CA, USA).
Results

Background Data
Of the 76 procedures analyzed, 48 were in males, 27 in females and in 1 the gender was not disclosed. Patients' ages ranged from 1 month to 23 years (6±5, mean ± standard deviation), and body weight ranged from 2.6 to 68.5 (25.9±18.2) kg. By echocardiography 34 of the affected valves were tricuspid with some fusion, 41 were bicuspid, and 1 was dysplastic. Calcification was present in only 2 valves. The aortic valve ring diameter ranged from 5 to 29.3 (16.7±5.7) mm, corresponding to 45.1-192.8 (113.7± 22.3) % of the normal value predicted by Kishimoto et al. 11 The aortic valve pressure gradient ranged from 20 to 140 (68±25) mmHg, and the grade of AR was none in 49, trivial in 14, and slight in 13. PTAV was performed with a single balloon in 40 procedures, and in 36 a double balloon was used. The balloon diameter varied from 5 to 29 (15±5) mm, and the balloon diameter/the diameter of the aortic valve ring ratio ranged from 0.7 to 1.4 (0.9±0.1). There were 30 complicating anomalies reported in 28 patients ( Table 1) .
Effect of PTAV
The pressure gradient was significantly decreased from 68±25 (range, 20-140) mmHg to 33±22 (0-100) mmHg (p<0.01). AR increased at least 1 grade in 26 (34%, p<0.01) procedures. There were 6 procedure-related complications, including thrombosis of the femoral artery, ventricular fibrillation, atrioventricular block, heart failure, pseudoaneurysm in the ascending aorta, and acute myocardial infarction. The first 3 of these patients recovered with medical treatment, surgery was required for the pseudoaneurysm, and the patient who developed a myocardial infarction died.
The pressure gradient reduction was judged as good in 44 of the 76 procedures (58%) and in this group, the pressure gradient decreased from 68±25 (42-140) mmHg to 21±12 (0-47) mmHg, and AR increased at least 1 grade in 18 (41%). The outcome of PTAV was disappointing in 32 procedures in which group the pressure gradient changed from 67±31 (20-120) mmHg to 51±21 (8-100) mmHg, and AR also increased at least 1 grade in 8 (25%) cases.
There was no significant difference in age, gender, bodyweight, valve morphology, calcification, the percentage of the actual ring diameter to the normal predictive diameter (%N), when comparing the good and poor outcome groups. Nor did pressure gradient prior to the procedure, the number of balloons used, and the ratio balloon diameter/the diameter of the aortic valve ring, effect the outcome. In the good effect group, the diameter of the valve ring, the balloon diameter, the ratio balloon diameter/the normal predicted diameter of the aortic valve ring were significantly greater than in the poor effect group (Table 2) .
AR increased by more than 2 grades in 9 (2 grades, 8; 3 grades, 1) of 76 (12%) procedures. In this group, the pressure gradient decreased from 74±23 (42-120) mmHg to 31±26 (0-70) mmHg, and AR changed from none (7) or trivial (2) to slight (6) or moderate (3), respectively (Fig 1) . AR remained unchanged in 50 procedures and increased by 1 grade in 17, and in this group, the gradient decreased from 67±25 (20-140) mmHg to 33±22 (0-100) mmHg. The actual AR also increased from none (42), trivial (12), slight (13) or moderate (0) to none (32), trivial (20), slight (10) or moderate (5), respectively (Fig 1) .
Between the worse outcome and the unchanged groups, there was no significant difference in age, gender, bodyweight, valve morphology, calcification, the diameter of the valve ring, the percentage of the actual ring diameter to the normal predictive diameter (%N), pressure gradient or grade of AR prior to the procedure, the number of balloons used, and the balloon diameter/the diameter of the aortic valve ring, the balloon diameter/the normal predicted diameter of the aortic valve ring, and percent change of pressure gradient caused by PTAV (pressure gradient before PTAVafter PTAV / before PTAV × 100; Table 4 ).
Follow-up
In the 44 procedures in which a good reduction in the pressure gradient was achieved, AR increased more than 2 grades in 5 cases, so we regarded 39 procedures (51%) as clinically effective. Of these, follow-up data from echocardiography or cardiac catheterization was available for 26 procedures. The follow-up interval was from 1 month to 10 years (4±3 years). AR progressed at least 1 grade in 11 (42%; 1 grade, 6; 2 grades, 5), and pressure gradient redeveloped to more than 50 mmHg in 2 (8%) cases.
Surgical Treatment
During the study period, 13 patients underwent surgical treatment of the aortic valve 1 month to 9 years after PTAV. Two patients underwent surgery following a second PTAV. In 5 patients inadequate reduction of the pressure gradient was the reason for surgery, whereas in 3 patients it was because of a residual pressure gradient and moderate AR complicated by PTAV. The indication for 2 patients was re-development of a pressure gradient of more than 50 mmHg, whereas for the other 3 patients it was severe AR, progressive moderate AR with residual pressure gradient, and pseudoaneurysm of the ascending aorta complicated by infective endocarditis, respectively (Table 4) . 4, 12, 13 PTAV is likely to be chosen as the treatment option for critical AS in newborns or early infancy, because other options are more risky. 8, 9 The best treatment choice for asymptomatic AS in children from among PTAV, homograft valve replacement, or the Ross operation 11,14,15, remains controversial.
Effect on the Pressure Gradient
On average, the pressure gradient decreased significantly following PTAV, although it was regarded as good in only 58% of procedures. The potential efficacy of PTAV could not be predicted from the background characteristics, such as age, bodyweight or valve morphology. Balloon diameter/the ring diameter did not differ between the good and poor outcome groups, as long as the balloon diameter/the ring diameter ratio was 0.9-1.0, as shown in this study, which we believe is the balloon size selected by most centers in Japan. In contrast, a larger ring diameter, larger balloon diameter, and larger balloon diameter/the normal predicted diameter of the aortic valve ring ratio significantly contributed to effective gradient reduction.
In the elderly, calcification of the valve is a major poor prognostic sign of PTAV outcome, but in the present group of children, we could not clarify the clinical significance of this change.
Increase in AR
AR increased by 1 grade in 17 procedures, 2 grades in 8, and 3 grades in 1. None of the parameters were predictive of an increase in AR greater than 2 grades. Consequently, great care should be taken to check AR during the procedure and if there is any indication of increased AR, even by 1 grade, the procedure should be abandoned.
Follow-up
Taking pressure gradient reduction and an increase in AR into account, we regarded 51% of PTAV procedures as being clinically effective. Subsequent progressive AR and re-development of the pressure gradient occurred during follow-up, even in clinically effective patients. Rao et al previously reported that a larger immediate gradient after PTAV was a risk factor for its subsequent re-development, 16 but we were unable to identify a factor that predicted such late deterioration, possibly because of a considerable lack of data.
Role of PTAV as a Treatment Option for AS
As PTAV can delay further intervention for several years provided it results in clinically effective dilatation, it offers the prospect of palliation for AS in children. However, as progressive AR and re-development of pressure gradient is not uncommon, even after clinically effective PTAV, we should not delay more definitive surgical treatment, such as the Konno or Ross operation for such patients. An increase in AR by more than 2 grades occurred in 12% of procedures and by 1 grade in 34%, so surgery should be the first choice for patients with moderate to severe AR and, furthermore, should not be delayed for patients with pulmonary hypertension, elevated left ventricular end-diastolic pressure or reduced left ventricular pump function, even if PTAV initially reduced any pressure gradient.
Study Limitations
As this study was a retrograde questionnaire survey, indications, procedures, interpretation of echocardiographic findings, or follow up plans were not standardized among the centers. There was also some lack of data, particularly during the follow up period.
